Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LETI SR is a specialized line of topical skincare products developed by Leti Pharma for the management of red and sensitive skin. It is designed to address conditions such as facial erythema, erythrosis, couperose, and rosacea subtype 1. The product range includes serums, creams, and micellar waters that utilize proprietary technologies like the 'Cathelicidin Equilibrium System' and 'Neurocosmetic Science'. These formulations incorporate active ingredients such as phytosterols, bioflavonoids, and phytopeptides to reduce redness, strengthen capillary walls, and repair the skin barrier. As an OTC/cosmetic line, it is hypoallergenic and non-comedogenic, focusing on soothing skin discomfort and providing anti-pollution and anti-aging benefits.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on LETI SR.